EN
HI
Alembic Pharmaceuticals Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
3.76 L
Market Cap
15412.51 CR
LTQ@LTP
10@784.10
ATP
785.7
Var Margin
16.14 %
Circuit Range
628.6-942.8
Delivery %
22.31 %
Value
29.55 CR
ASM/GSM
No
Market Lot
1
Summary
Alembic Pharmaceuticals share price is ₹784.1 as of 16 May, 2026. The stock Alembic Pharmaceuticals intraday movement has stayed between ₹769.50 and ₹809.00, while on a 52-week basis,Alembic Pharmaceuticals price 52 week high is ₹1107.90 & its 52 week low is ₹635.80.
In terms of trading activity, Alembic Pharmaceuticals has recorded a volume of 376042 shares, The Alembic Pharmaceuticals has a market cap of ₹196563124 CR. The stock’s Average Traded Price (ATP) stands at ₹785.70, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹784.10.
Alembic Pharmaceuticals operates within a circuit range of ₹628.60 – ₹942.80, with a Value of ₹29.55 CR. The Delivery Percentage for the day is 22.31%. Additionally, Alembic Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Alembic Pharmaceuticals Fundamentals
View MoreP/E Ratio
22.86
P/B Ratio
2.83
Div. Yield
1.4
Sector P/E
71.32
Sector P/B
3.47
Sec. Div. Yield
0.56
Alembic Pharmaceuticals Resistance and Support
Pivot 782.1
Resistance
First Resistance
794.2
Second Resistance
802.7
Third Resistance
814.8
Support
First Support
773.6
Second Support
761.5
Third Support
753
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Alembic Pharmaceuticals Limited Passes ANVISA (Brazil) GMP Inspection For Its API-III Facility At Karakhadi.
Alembic Pharma successfully completed the ANVISA (Brazil) GMP inspection for its API-III Facility at Karakhadi. This indicates compliance with Good Manufacturing Practices, crucial for continued operations and market access in Brazil.
May 15 2026 20:05:00
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharma announced Q4 FY26 results with revenue up 4% YoY to Rs.1,848 crore and net profit up 29% YoY to Rs.203 crore. The company also launched its US Branded Business, Pivya, during the quarter.
May 15 2026 14:05:00
Read More
About Alembic Pharmaceuticals
NSE : 25328
BSE : 533573
ISIN : INE901L01018
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Eris Lifesciences Ltd.
1370.90
-3.00 (0.22%)
Granules India Ltd.
736.20
0.90 (0.12%)
Cohance Lifesciences Ltd.
423.20
-22.00 (4.94%)
Poly Medicure Ltd.
1498.90
-22.10 (1.45%)
Jubilant Pharmova Ltd.
990.15
-14.25 (1.42%)
Dr. Agarwal's Health Care Ltd.
450.10
3.85 (0.86%)
Caplin Point Laboratories Ltd.
1998.80
-25.00 (1.24%)
Vijaya Diagnostic Centre Ltd.
1329.20
59.30 (4.67%)
Rainbow Children's Medicare Ltd.
1336.20
20.00 (1.52%)
Alivus Life Sciences Ltd.
1044.60
-19.50 (1.83%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 784.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 22.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.83. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 15412.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.90 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
